Evangelos Kyprios, DPM | |
2601 Thornton Ln, 200, Temple, TX 76502-1808 | |
(254) 935-5800 | |
(254) 935-5806 |
Full Name | Evangelos Kyprios |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 9 Years |
Location | 2601 Thornton Ln, Temple, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992188452 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | T67-2015 (Texas) | Secondary |
213ES0103X | Podiatrist - Foot & Ankle Surgery | 0103301240 (Virginia) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Jeremiah Graff Dpm P A | 4789745027 | 7 |
News Archive
Excaliber Enterprises, Ltd. announced today that its wholly-owned subsidiary has merged with VistaGen Therapeutics, Inc., a private biotechnology company focused on stem cell-based drug rescue and drug development. As a result of the Merger, VistaGen is a wholly-owned subsidiary of Excaliber.
Use of prescription drugs in the U.S. declined in 2008 - the first such decrease in a decade - but total spending on such treatments increased by 3.3%, according to a report released on Wednesday by Medco Health Solutions, the AP/Washington Post reports.
A concerted R&D effort directed at triple-negative breast cancer patients promises new treatment options in the near future, according to latest research from independent market analyst, Datamonitor.
Cancer care has dramatically changed as a result of the measures taken during the COVID-19 pandemic: many patients have not been going to their GPs, or putting it off, and have been referred to the hospital later.
› Verified 5 days ago
Provider Name | Jeremiah Graff Dpm P A |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1588809560 PECOS PAC ID: 4789745027 Enrollment ID: O20081205000189 |
News Archive
Excaliber Enterprises, Ltd. announced today that its wholly-owned subsidiary has merged with VistaGen Therapeutics, Inc., a private biotechnology company focused on stem cell-based drug rescue and drug development. As a result of the Merger, VistaGen is a wholly-owned subsidiary of Excaliber.
Use of prescription drugs in the U.S. declined in 2008 - the first such decrease in a decade - but total spending on such treatments increased by 3.3%, according to a report released on Wednesday by Medco Health Solutions, the AP/Washington Post reports.
A concerted R&D effort directed at triple-negative breast cancer patients promises new treatment options in the near future, according to latest research from independent market analyst, Datamonitor.
Cancer care has dramatically changed as a result of the measures taken during the COVID-19 pandemic: many patients have not been going to their GPs, or putting it off, and have been referred to the hospital later.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Evangelos Kyprios, DPM 222 Walnut Ave Sw, Roanoke, VA 24016-4723 Ph: (540) 344-3668 | Evangelos Kyprios, DPM 2601 Thornton Ln, 200, Temple, TX 76502-1808 Ph: (254) 935-5800 |
News Archive
Excaliber Enterprises, Ltd. announced today that its wholly-owned subsidiary has merged with VistaGen Therapeutics, Inc., a private biotechnology company focused on stem cell-based drug rescue and drug development. As a result of the Merger, VistaGen is a wholly-owned subsidiary of Excaliber.
Use of prescription drugs in the U.S. declined in 2008 - the first such decrease in a decade - but total spending on such treatments increased by 3.3%, according to a report released on Wednesday by Medco Health Solutions, the AP/Washington Post reports.
A concerted R&D effort directed at triple-negative breast cancer patients promises new treatment options in the near future, according to latest research from independent market analyst, Datamonitor.
Cancer care has dramatically changed as a result of the measures taken during the COVID-19 pandemic: many patients have not been going to their GPs, or putting it off, and have been referred to the hospital later.
› Verified 5 days ago
Richard N Goad, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 Fax: 254-724-7603 | |
Dr. Edward T. Mccaffrey, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1717 Sw H K Dodgen Loop, Temple, TX 76502 Phone: 254-298-2682 Fax: 254-778-7197 | |
Lily Raga, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2601 Thornton Ln Ste 200, Temple, TX 76502 Phone: 254-935-5750 | |
Jonathan Lorenzana, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2601 Thornton Ln, Temple, TX 76502 Phone: 254-935-5730 | |
Dr. John Marshall Devall, D.P.M. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1402 W Avenue H, Temple, TX 76504 Phone: 254-771-8411 | |
Frank Felix, Podiatrist Medicare: Medicare Enrolled Practice Location: 2601 Thornton Ln, Temple, TX 76502 Phone: 254-724-2111 | |
Dr. Christopher Glenn Browning, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2601 Thornton Ln, Temple, TX 76502 Phone: 254-724-6622 Fax: 254-742-6620 |